Australia's most trusted
source of pharma news
Posted 16 July 2026 PM
Telix has opened a first-of-its-kind Australian facility intended to significantly reduce the timeframe from early-stage trials to broad patient access for radiopharmaceuticals while boosting the nations sovereign manufacturing capacity.
The new multi-million dollar facility, Telix Manufacturing Solutions North Melbourne (TMSNM), is a collaboration with Melbourne Theranostic Innovation Centre (MTIC) where it is located, and combines radiopharmaceutical research, manufacturing, and treatment. It was officially opened today, with former Health Minister Greg Hunt on the guest list.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.